Member Contact: Tina Soulis
Position: General Manager
Industry: R&D Services
Neuroscience Trials Australia (NTA) is an Australian-based, niche, full service, contract research organization (CRO) specializing in all aspects of clinical research and early phase work (in particular).
With an average of 14 plus years plus industry experience, our staff routinely work with pharmaceutical, biotechnology, cell therapy and device companies to undertake their clinical trials according to global regulatory standards such that the data we collect is acceptable to regulatory authorities such as the TGA, FDA and EMA (in Europe).
As a wholly owned business within The Florey Institute of Neuroscience and Mental Health (The Florey), Neuroscience Trials Australia (NTA) has strategic alliances with many therapeutic disease groups and we can provide access to key opinion leaders, experienced sites and clinical trial expertise through a range of tailored services. On a daily basis we interact with up to 200 CNS-focused sites alone. Any profit that we may make on a project is re-directed back into neuroscience academic research at The Florey.
Areas of expertise include include epilepsy, stroke and stroke-related conditions, Alzheimer’s disease/cognitive disease studies, multiple sclerosis, rare and pediatric diseases, mental health and associated conditions, Parkinson’s disease, spinal cord injuries, Huntington’s disease, neurosurgery, pain, neuromuscular disease and migraine and Phase I studies